DexCom (DXCM) Stock Forecast & Price Target
Score
DexCom, Inc. price target
| DXCM | |
|---|---|
| Low | $86.00 |
| Average | $97.85 |
| High | $115.00 |
| Upside vs current price | +19.2% |
The average target of $97.85 is +19.2% versus the current DXCM price of $82.12.
DexCom, Inc. analyst ratings
| Rating | Analysts |
|---|---|
| Strong buy | 4 |
| Buy | 22 |
| Hold | 3 |
| Sell | 0 |
| Strong sell | 0 |
| Consensus | Buy |
29 analysts cover DXCM.
DexCom, Inc. EPS and revenue estimates
DXCM shows the next fiscal years with at least three analysts: 2026 EPS $2.70, 2027 EPS $3.13. A thinner year is left off this table.
| Fiscal year | EPS estimate | Revenue estimate |
|---|---|---|
| 2026 | $2.70 | $5.23B |
| 2027 | $3.13 | $5.76B |
Is DexCom, Inc. a buy or sell?
Of the 29 analysts covering DexCom, Inc., 26 rate it a buy (4 strong buy and 22 buy), 3 rate it a hold, and 0 rate it a sell (0 sell and 0 strong sell).
The DXCM consensus label is Buy, beside 26 buy-side ratings and 0 sell-side ratings.
The average target of $97.85 implies +19.2% versus the current price of $82.12.
Those 29 ratings on DXCM are a headcount, and the label on file is Buy.
Reading the DexCom, Inc. forecast
The DXCM target band runs from $86.00 to $115.00. The average inside that band is $97.85.
Set next to the $82.12 DXCM quote, that average is +19.2%.
Ratings on the DexCom, Inc. cluster: 26 of 29 analysts are on the buy side, 3 are at hold, and 0 are on the sell side, and the published consensus is Buy.
The DXCM average target is little changed, $104.00 over the last month and $103.80 over the last quarter.
29 analysts publish on DXCM, so one note does not swing the average by itself.
DexCom, Inc. forecast questions
What is the DXCM price target?
The published range for DXCM is $86.00 to $115.00, with an average of $97.85. That average is +19.2% versus the current price of $82.12.
Is DexCom, Inc. a buy or sell?
Of the 29 analysts covering DexCom, Inc., 26 rate it a buy, 3 rate it a hold, and 0 rate it a sell. The consensus is Buy, and the DXCM headcount is 26 buy, 3 hold, and 0 sell.
What is the EPS estimate for DexCom, Inc.?
Analyst EPS estimates for DexCom, Inc.: 2026 $2.70, 2027 $3.13.
What is the revenue estimate for DexCom, Inc.?
Analyst revenue estimates for DexCom, Inc.: 2026 $5.23B, 2027 $5.76B.
How many analysts cover DXCM?
29 analysts cover DXCM. Their consensus on DXCM is Buy, across those 29.